Riboflavin Deficiency 

  • Author: Mary Zoe Baker, MD; Chief Editor: George T Griffing, MD   more...
 
Updated: Dec 6, 2011
 

Overview

Riboflavin, or vitamin B-2, was initially isolated from milk whey in 1879. Originally called lactochrome, it was also once known as vitamin G. Riboflavin is important for energy production, enzyme function, and normal fatty acid and amino acid synthesis and is necessary for the reproduction of glutathione, a free radical scavenger. The water-soluble B factor consists of 2 separate ingredients; one is unstable when heated, while the other remains stable. The less stable factor was named vitamin F (thiamine), while the heat-stable product was labeled vitamin G. They were later renamed vitamins B-1 and B-2, respectively.

Riboflavin functions in several different enzyme systems. Two derivatives, riboflavin 5' phosphate (flavin mononucleotide [FMN]) and riboflavin 5' adenosine diphosphate (flavin adenine dinucleotide [FAD]), are the coenzymes that unite with specific apoenzyme proteins to form flavoprotein enzymes. Most of the flavin coenzyme systems help regulate cellular metabolism, whereas others are specifically involved in carbohydrate or amino acid metabolism systems. Riboflavin also appears to have a role in fat metabolism. [1]

Water-soluble riboflavin is not stored in ample amounts; minute reserves are stored in the liver, kidneys, and heart. A constant supply is needed. Deficiency in this vitamin is usually part of a multiple-nutrient deficiency and does not occur in isolation. Some authorities claim that riboflavin deficiency is the most common nutrient deficiency in the United States; however, riboflavin deficiency is generally considered to be uncommon in the United States because of fortification of many foods, including grains and cereals.

Riboflavin deficiency is usually associated with other vitamin B complex deficiencies; isolated riboflavin deficiency is rare.[2]

Riboflavin in the diet

Milk and other dairy products make the greatest contributions of riboflavin in western diets. Other common dietary sources include cereals, meats, and dark green vegetables (eg, spinach, asparagus, and broccoli). Riboflavin deficiency can occur with a diet deficient in these riboflavin-rich foods. Additionally, glass milk containers promote degradation of the vitamin from exposure to light. Daily consumption of breakfast cereal and milk would be expected to provide an adequate intake of riboflavin.

The condition is more commonly seen in persons with such risk factors as pregnancy,[3] lactation, phototherapy for hyperbilirubinemia (in premature infants), advanced age,[4] low income, and/or depression. Riboflavin is absorbed in the proximal small intestine. Malabsorption from such conditions as celiac sprue, malignancies, and alcoholism can also promote deficiency of riboflavin.

Riboflavin is transported in the bloodstream as a flavin-protein complex, which means that nonavailability of the carrier protein also leads to apparent riboflavin deficiency. Similarly, it is possible for antagonists to interfere with absorption and/or transport and thus create an apparent deficiency at receptor sites.[5]

Next

Riboflavin Requirements

The recommended nutrient intake (RNI) of riboflavin is 0.6 mg/5000 kJ daily. The daily RNI ranges are as follows:

  • 0.3-0.6 mg for infants
  • 0.7-1.1 mg for children
  • 1.1-1.4 mg for adolescents
  • 1-1.6 mg for adults

Oral riboflavin doses of 1-4 mg daily are usually considered sufficient as a nutritional supplement in patients with normal GI absorption. These doses should be present in the normal diet.

Recommended increased requirements for pregnant and lactating women are as follows:

  • Additional 0.1 mg/day in the first trimester
  • Additional 0.3 mg/day in the second and third trimesters
  • Additional 0.4 mg/day during lactation
Previous
Next

Clinical Features of Deficiency

Dermatologic manifestations of riboflavin deficiency include cheilosis, or chapping and fissuring of the lips (see the image below); a sore, red tongue; and oily, scaly skin rashes on the scrotum, vulva, and philtrum.

Riboflavin deficiency is often associated with cheRiboflavin deficiency is often associated with cheilosis (chapping and fissuring of the lips).
  • The following may also be manifestations of riboflavin deficiency:
  • Red, itchy eyes
  • Night blindness
  • Cataracts
  • Migraines
  • Peripheral neuropathy
  • anemia (secondary to interference with iron absorption)
  • Fatigue
  • Malignancy (esophageal and cervical dysplasia)

Deficiency can be associated with developmental abnormalities, such as the following:

  • Cleft lip and palate deformities (see the image below)Riboflavin deficiency can be associated with varioRiboflavin deficiency can be associated with various developmental abnormalities, including cleft lip.
  • Growth retardation in infants and children: results from the National Birth Defects Prevention Study, which included an investigation of 324 infants with transverse limb deficiency (TLD), indicated that low maternal dietary intake of riboflavin is a risk factor for TLD[6]
  • Congenital heart defects: a study from the Netherlands indicated that a maternal diet that is high in saturated fats and low in riboflavin and nicotinamide may increase the risk for congenital heart defects[7]
Previous
Next

Laboratory Findings

Measurement of red blood cell glutathione reductase activity may help in the detection of riboflavin deficiency.[8] An increase in the stimulation of this enzymatic reaction confirms a low level of riboflavin.

Riboflavin can cause false elevations of urinary catecholamines and false-positive urine urobilinogen reactions (Ehrlich test).

Previous
Next

Riboflavin Replenishment

Treatment of riboflavin deficiency consists of riboflavin replenishment, with care taken not to overlook coexisting B-complex deficiencies. Multivitamins have no documented role, because the physician must establish the presence of individual vitamin deficiencies and correct them appropriately. This prevents toxicities and masking of the clinical picture.[9, 10]

Except in malabsorption syndromes, riboflavin is readily absorbed from the upper GI tract. The extent of GI absorption is increased when the drug is administered with food and is decreased in patients with hepatitis, cirrhosis, and biliary obstruction.

Riboflavin is a water-soluble vitamin, is considered nontoxic, and has no known adverse effects; Riboflavin should be taken with food, because only about 15% is absorbed when taken alone on an empty stomach; excess riboflavin is excreted in urine, giving the urine a fluorescent yellow-green tint.[5]

Dosages of riboflavin for deficiency treatment are as follows:

  • Age < 3 years: not established
  • Age 3-12 years: 3-10 mg PO divided daily
  • Age >12 years: Administer as in adults (see below)
  • Adult dose: 6-30 mg PO divided daily for replacement when deficiency is suspected

The biologic half-life of riboflavin is about 66-84 minutes following oral or intramuscular administration of a single large dose in healthy individuals. Only about 9% of the drug is excreted unchanged. Excretion appears to involve renal tubular secretion as well as glomerular filtration. Amounts in excess of the body's needs are excreted in urine.

As a photosynthesizing agent, riboflavin is destroyed by light. A combination of light, oxygen, and riboflavin can lead to formation of free radicals and, consequently, cataracts; patients with cataracts are advised to take no more than 10 mg of riboflavin daily

Previous
 
Contributor Information and Disclosures
Author

Mary Zoe Baker, MD  Professor, Department of Medicine, Section of Endocrinology, Metabolism and Hypertension, University of Oklahoma College of Medicine; Medical Director, Medicine Specialty Clinic, General Medicine Clinic and Medicine Residents' Clinic, University of Oklahoma Physicians

Mary Zoe Baker, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, American Chemical Society, and American College of Physicians-American Society of Internal Medicine

Disclosure: Nothing to disclose.

Chief Editor

George T Griffing, MD  Professor of Medicine, St Louis University School of Medicine

George T Griffing, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Medical Practice Executives, American College of Physician Executives, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical Research, Endocrine Society, International Society for Clinical Densitometry, and Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Additional Contributors

Mark R Allee, MD Associate Professor, Department of Medicine, University of Oklahoma Health Sciences Center

Mark R Allee, MD is a member of the following medical societies: American College of Physicians

Disclosure: Nothing to disclose.

Don S Schalch, MD Professor Emeritus, Department of Internal Medicine, Division of Endocrinology, University of Wisconsin Hospitals and Clinics

Don S Schalch, MD is a member of the following medical societies: American Diabetes Association, American Federation for Medical Research, Central Society for Clinical Research, and Endocrine Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

Stanley Wallach, MD Executive Director, American College of Nutrition; Clinical Professor, Department of Medicine, New York University School of Medicine

Stanley Wallach, MD is a member of the following medical societies: American Society for Bone and Mineral Research, American Society for Clinical Investigation, American Society for Clinical Nutrition, American Society for Nutritional Sciences, Association of American Physicians, and Endocrine Society

Disclosure: Nothing to disclose.

Frederick H Ziel, MD Associate Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Physician-In-Charge, Endocrinology/Diabetes Center, Director of Medical Education, Kaiser Permanente Woodland Hills; Chair of Endocrinology, Co-Chair of Diabetes Complete Care Program, Southern California Permanente Medical Group

Frederick H Ziel, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Diabetes Association, American Federation for Medical Research, American Medical Association, American Society for Bone and Mineral Research, California Medical Association, Endocrine Society, andInternational Society for Clinical Densitometry

Disclosure: Nothing to disclose.

References
  1. Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr. Jun 2003;77(6):1352-60. [Medline]. [Full Text].

  2. McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr. Jun 2008;99 Suppl 3:S48-54. [Medline].

  3. Ma AG, Schouten EG, Zhang FZ, et al. Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic Acid supplements. J Nutr. Oct 2008;138(10):1946-50. [Medline].

  4. Yazdanpanah N, Uitterlinden AG, Zillikens MC, et al. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J Bone Miner Res. Jan 2008;23(1):86-94. [Medline].

  5. Moriyama Y. Riboflavin transporter is finally identified. J Biochem. Oct 2011;150(4):341-3. [Medline].

  6. Robitaille J, Carmichael SL, Shaw GM, et al. Maternal nutrient intake and risks for transverse and longitudinal limb deficiencies: data from the National Birth Defects Prevention Study, 1997-2003. Birth Defects Res A Clin Mol Teratol. Apr 6 2009;[Medline].

  7. Smedts HP, Rakhshandehroo M, Verkleij-Hagoort AC, et al. Maternal intake of fat, riboflavin and nicotinamide and the risk of having offspring with congenital heart defects. Eur J Nutr. Oct 2008;47(7):357-65. [Medline].

  8. Hoey L, McNulty H, Strain J. Studies of biomarker responses to intervention with riboflavin: a systematic review. Am J Clin Nutr. Apr 29 2009;[Medline].

  9. Russell, RM. Vitamin and trace mineral deficiency and excess. In: Kasper DL, Braunwald E, Fauci AS, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:403-11.

  10. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia. Oct 1994;14(5):328-9. [Medline].

Previous
Next
 
Riboflavin deficiency is often associated with cheilosis (chapping and fissuring of the lips).
Riboflavin deficiency can be associated with various developmental abnormalities, including cleft lip.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.